Intersection of Brain Development and Paediatric Diffuse Midline Gliomas: Potential Role of Microenvironment in Tumour Growth

Por Loveson, Katie F., Fillmore, Helen L.
Publicado no Brain Sci (2018)

GENE-14. UNIQUE MOLECULAR AND CLINICAL FEATURES OF LI-FRAUMENI SYNDROME ASSOCIATED BRAIN TUMOURS

Por Zapotocky, Michal, Misove, Adela, Vlckova, Marketa, Krskova, Lenka, Zamecnik, Josef, Vanova, Katerina, Malinova, Bela, Ondrova, Barbora, Pernikova, Ivana, Vicha, Ales, Tichy, Michal, Liby, Petr, Kyncl, Martin, Ramaswamy, Vijay, Sumerauer, David
Publicado no Neuro Oncol (2019)

Brain tumour necrosis factor-α modulates neurotransmitters in hypothalamic paraventricular nucleus in heart failure

Por Kang, Yu-Ming, He, Rong-Li, Yang, Li-Min, Qin, Da-Nian, Guggilam, Anuradha, Elks, Carrie, Yan, Ning, Guo, Zheng, Francis, Joseph
Publicado em 2009

HOW SHOULD WE SUPPORT PATIENTS WITH PRIMARY BRAIN TUMOURS WHO ELECT TO TAKE CANNABINOIDS?

Por La, Jessica, Hurwitz, Victoria, Mullens, Laura, Brazil, Lucy, Gullan, Richard, Bhangoo, Ranj, Vergani, Francesco, Beaney, Ronald, Ashkan, Keyoumars, Rooprai, Bali, Swampillai, Angela
Publicado no Neuro Oncol (2018)

A prognostic index that predicts outcome following palliative whole brain radiotherapy for patients with metastatic malignant melanoma

Por Morris, S L, Low, S H, A'Hern, R P, Eisen, T G, Gore, M E, Nutting, C M, Harrington, K J
Publicado em 2004

Chlorpromazine specifically inhibits peripheral and brain TNF production, and up-regulates IL-10 production, in mice.

Por Mengozzi, M, Fantuzzi, G, Faggioni, R, Marchant, A, Goldman, M, Orencole, S, Clark, B D, Sironi, M, Benigni, F, Ghezzi, P
Publicado em 1994

Tumour Necrosis Factor-α Inhibition Improves Stroke Outcome in a Mouse Model of Rheumatoid Arthritis

Por Bonetti, N. R., Diaz-Cañestro, C., Liberale, L., Crucet, M., Akhmedov, A., Merlini, M., Reiner, M. F., Gobbato, S., Stivala, S., Kollias, G., Ruschitzka, F., Lüscher, T. F., Beer, J. H., Camici, G. G.
Publicado no Sci Rep (2019)

Treatment for glioblastoma multiforme: current guidelines and Canadian practice

Por Ghose, A., Lim, G., Husain, S.
Publicado em 2010

Nanotechnology—novel therapeutics for CNS disorders

Por Srikanth, Maya, Kessler, John A.
Publicado em 2012

Provincial Disparities of Growth Hormone Coverage for Young Adult Survivors of Paediatric Brain Tumours across Canada

Por Hasan, Haroon, Howard, Fuchsia, Morgan, Steven G., Metzger, Daniel L., Gill, Sabrina, Johnson, Michelle, Lo, Andrea C., Goddard, Karen
Publicado em 2014

Intravenous versus inhalational techniques for rapid emergence from anaesthesia in patients undergoing brain tumour surgery

Por Prabhakar, Hemanshu, Singh, Gyaninder Pal, Mahajan, Charu, Kapoor, Indu, Kalaivani, Mani, Anand, Vidhu
Publicado no Cochrane Database Syst Rev (2016)

Modelling glioblastoma tumour-host cell interactions using adult brain organotypic slice co-culture

Por Marques-Torrejon, Maria Angeles, Gangoso, Ester, Pollard, Steven M.
Publicado no Dis Model Mech (2018)

Verteporfin selectively kills hypoxic glioma cells through iron-binding and increased production of reactive oxygen species

Por Eales, Katherine L., Wilkinson, Edward A., Cruickshank, Garth, Tucker, James H. R., Tennant, Daniel A.
Publicado no Sci Rep (2018)

OP23 AN AUDIT TO ASSESS PSYCHIATRIC CONDITIONS THAT MANIFEST IN PATIENTS WITH HIGH-GRADE BRAIN TUMOURS DURING TREATMENT

Por Knighton, Craig, Logan, Jamie, Hurwitz, Vicky, King, Alex, Hodgkiss, Andrew, Cikurel, Katia, Beaney, Ron, Brazil, Lucy
Publicado em 2014

Induction of HSP70 is associated with vincristine resistance in heat-shocked 9L rat brain tumour cells.

Por Lee, W. C., Lin, K. Y., Chen, K. D., Lai, Y. K.
Publicado em 1992

P08.64 5-ALA fluorescence-guided surgical resection of glioblastoma in the elderly

Por Oppido, P. A., Carapella, C. M.
Publicado no Neuro Oncol (2016)

EPID-16. REVIEW OF CLINICAL PRESENTATION AND DIAGNOSIS INTERVAL IN PEDIATRIC PATIENTS WITH PRIMARY BRAIN TUMOURS IN WESTERN UKRAINE

Por Kizyma, Roman, Kizyma, Zoryana, Kotsay, Bogdan, Dvornyak, Oleksandra, Shchurovska, Iryna, Mykytyn, Taras, Biganych, Konstyantin
Publicado no Neuro Oncol (2018)

Increased signalling of EGFR and IGF1R, and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas

Por Gallardo, A, Lerma, E, Escuin, D, Tibau, A, Muñoz, J, Ojeda, B, Barnadas, A, Adrover, E, Sánchez-Tejada, L, Giner, D, Ortiz-Martínez, F, Peiró, G
Publicado em 2012

P03.04 SENSITIZING GLIOBLASTOMA CELLS TO THERAPY BY TARGETING THE L-GLUTAMATE/L-CYSTINE ANTIPORTER SYSTEM XC-

Por Kolb, A.K., Piccirillo, S., Watts, C.
Publicado em 2014

Biodegradable interstitial release polymer loading a novel small molecule targeting Axl receptor tyrosine kinase and reducing brain tumour migration and invasion

Por Yen, S-Y, Chen, S-R, Hsieh, J, Li, Y-S, Chuang, S-E, Chuang, H-M, Huang, M-H, Lin, S-Z, Harn, H-J, Chiou, T-W
Publicado no Oncogene (2016)